Test Research (Taiwan) Performance
| 3030 Stock | TWD 133.50 3.50 2.55% |
The entity has a beta of 0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Test Research's returns are expected to increase less than the market. However, during the bear market, the loss of holding Test Research is expected to be smaller as well. At this point, Test Research has a negative expected return of -0.22%. Please make sure to validate Test Research's total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Test Research performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Test Research has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors. ...more
| Begin Period Cash Flow | 1.6 B | |
| Total Cashflows From Investing Activities | -108.5 M |
Test |
Test Research Relative Risk vs. Return Landscape
If you would invest 16,250 in Test Research on August 29, 2024 and sell it today you would lose (2,550) from holding Test Research or give up 15.69% of portfolio value over 90 days. Test Research is generating negative expected returns and assumes 3.1916% volatility on return distribution over the 90 days horizon. Simply put, 28% of stocks are less volatile than Test, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Test Research Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Test Research's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Test Research, and traders can use it to determine the average amount a Test Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.069
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 3030 |
Estimated Market Risk
| 3.19 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Test Research is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Test Research by adding Test Research to a well-diversified portfolio.
Test Research Fundamentals Growth
Test Stock prices reflect investors' perceptions of the future prospects and financial health of Test Research, and Test Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Test Stock performance.
| Return On Equity | 0.29 | |||
| Return On Asset | 0.15 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 14.71 B | |||
| Shares Outstanding | 236.22 M | |||
| Price To Earning | 10.07 X | |||
| Price To Book | 2.23 X | |||
| Price To Sales | 2.31 X | |||
| Revenue | 5.61 B | |||
| EBITDA | 1.7 B | |||
| Cash And Equivalents | 1.52 B | |||
| Cash Per Share | 6.44 X | |||
| Total Debt | 7.06 M | |||
| Debt To Equity | 0.10 % | |||
| Book Value Per Share | 29.43 X | |||
| Cash Flow From Operations | 591.41 M | |||
| Earnings Per Share | 7.83 X | |||
| Total Asset | 8.01 B | |||
| Retained Earnings | 2.6 B | |||
| Current Asset | 4.71 B | |||
| Current Liabilities | 1.84 B | |||
About Test Research Performance
Evaluating Test Research's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Test Research has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Test Research has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Test Research, Inc. provides PCBA testing and inspection products. Test Research, Inc. was founded in 1989 and is headquartered in Taipei City, Taiwan. TEST RESEARCH operates under Scientific Technical Instruments classification in Taiwan and is traded on Taiwan Stock Exchange.Things to note about Test Research performance evaluation
Checking the ongoing alerts about Test Research for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Test Research help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Test Research generated a negative expected return over the last 90 days | |
| Test Research has high historical volatility and very poor performance | |
| About 35.0% of the company shares are owned by insiders or employees |
- Analyzing Test Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Test Research's stock is overvalued or undervalued compared to its peers.
- Examining Test Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Test Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Test Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Test Research's stock. These opinions can provide insight into Test Research's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Test Stock Analysis
When running Test Research's price analysis, check to measure Test Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Test Research is operating at the current time. Most of Test Research's value examination focuses on studying past and present price action to predict the probability of Test Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Test Research's price. Additionally, you may evaluate how the addition of Test Research to your portfolios can decrease your overall portfolio volatility.